tirzepatide in vienna vs Semaglutide: 2025 NEJM Study Reveals Superior Weight Loss Mounjaro Injections in Vienna -

Importantly, body composition analyses using dual-energy X-ray absorptiometry (DEXA) scans revealed that the majority of weight lost was fat mass rather than lean muscle tissue

Some side effects are usually not severe

If you are pregnant or plan to become pregnant, you should not use tirzepatide

For the right patient, it's the tool that keeps the result holding

Beyond weight regain, stopping GLP-1 and GIP/GLP-1 medications triggers several physiological changes that patients should anticipate

Selena Raines, DO Osteopathic physician Member, American Osteopathic Association Disclosures: Raines reports no relevant financial disclosures